Overview

Evaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies

Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
A phase I clinical study evaluating LBL-003 in the treatment of subjects with advanced solid tumors .
Phase:
Phase 1
Details
Lead Sponsor:
Nanjing Leads Biolabs Co.,Ltd